< Terug naar vorige pagina
Octrooi
Bace1 inhibitory antibodies
The present invention relates to antibodies with a specificity for BACE1. More specifically, the invention provides monoclonal antibodies which bind to BACE1 and are capable of inhibiting the activity of BACE1 and methods producing these antibodies. Said antibodies can be used for research and medical applications. Specific applications include the use of BACE1 specific antibodies for the treatment of Alzheimer's disease.
Octrooi-publicatienummer: EP2443149
Jaar aanvraag: 2010
Jaar toekenning: 2016
Jaar van publicatie: 2016
Status: Toegewezen
URI: link to Espacenet
Technologiedomeinen: Farmaceutische producten
Gevalideerd voor IOF-sleutel: Ja
Toegewezen aan: Associatie KULeuven